ISOLATED PERFUSED CIRRHOTIC HUMAN LIVER OBTAINED FROM LIVER-TRANSPLANT PATIENTS - A FEASIBILITY STUDY

被引:11
作者
VILLENEUVE, JP
HUET, PM
GARIEPY, L
FENYVES, D
WILLEMS, B
COTE, J
LAPOINTE, R
MARLEAU, D
机构
[1] UNIV MONTREAL,ANDRE VIALLET CLIN RES CTR,DEPT PATHOL,MONTREAL H2X 1P1,QUEBEC,CANADA
[2] UNIV MONTREAL,ANDRE VIALLET CLIN RES CTR,DEPT SURG,MONTREAL H2X 1P1,QUEBEC,CANADA
[3] UNIV MONTREAL,HOP ST LUC,MONTREAL,QUEBEC,CANADA
关键词
D O I
10.1002/hep.1840120212
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Cirrhotic livers obtained from eight patients who underwent orthotopic liver transplantation were perfused through the portal vein and hepatic artery in a closed recycling system for periods ranging from 2 to 7 hr. An average perfusion flow of 451 ml/min was used, with about 80% coming from the portal vein and 20% from the hepatic artery. The livers appeared to remain viable as assessed by gross appearance, stable portal vein and hepatic artery pressures, oxygen consumption and bile prodúction. The extraction ratio of indocyanine green by the perfused livers averaged 0.098 (range = 0.023 to 0.168); that of propranolol averaged 0.445 (range = 0.126 to 0.813). Using the multipleindicator dilution‐curve method, shunts >15 μm in diameter were demonstrated between the portal and hepatic veins in six of eight cases, whereas shunts from the hepatic artery to the hepatic veins were absent. Perfusion of human livers obtained during hepatic transplantation is a fairly simple procedure that will allow researchers to gain new insights into cirrhosis in humans. (HEPATOLOGY 1990;12:257–263). Copyright © 1990 American Association for the Study of Liver Diseases
引用
收藏
页码:257 / 263
页数:7
相关论文
共 12 条
[1]  
CAESAR J, 1961, CLIN SCI, V21, P43
[2]  
COTHAM RH, 1975, CLIN PHARMACOL THER, V18, P535
[3]   THE ISOLATED PERFUSED-RAT-LIVER - CONCEPTUAL AND PRACTICAL CONSIDERATIONS [J].
GORES, GJ ;
KOST, LJ ;
LARUSSO, NF .
HEPATOLOGY, 1986, 6 (03) :511-517
[4]  
GORESKY CA, 1963, AM J PHYSIOL, V204, P626
[5]  
HUET PM, 1983, HEPATOLOGY, V3, P913
[6]   INTRAHEPATIC CIRCULATION IN LIVER-DISEASE [J].
HUET, PM ;
POMIERLAYRARGUES, G ;
VILLENEUVE, JP ;
VARIN, F ;
VIALLET, A .
SEMINARS IN LIVER DISEASE, 1986, 6 (04) :277-286
[7]  
KORNHAUSER DM, 1978, CLIN PHARMACOL THER, V23, P165
[8]   PROTEIN-BINDING AND HEPATIC-CLEARANCE - DISCRIMINATION BETWEEN MODELS OF HEPATIC-CLEARANCE WITH DIAZEPAM, A DRUG OF HIGH INTRINSIC CLEARANCE, IN THE ISOLATED PERFUSED-RAT-LIVER PREPARATION [J].
ROWLAND, M ;
LEITCH, D ;
FLEMING, G ;
SMITH, B .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1984, 12 (02) :129-147
[9]  
TAMAYO RP, 1983, HEPATOLOGY, V3, P112
[10]   HEPATIC MICROCIRCULATION IN THE PERFUSED CIRRHOTIC RAT-LIVER [J].
VARIN, F ;
HUET, PM .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (05) :1904-1912